MIAMI, March 22, 2021 – US Customs seized and disposed of tons of low quality Malaysian-made gloves in recent days leaving a void in the medical glove supply chain that was filled by V12 Health®. The company stepped up and increased manufacturing capacity to yield essential industry orders with their acclaimed product.
“A lot of people will be furious this week because they spent millions of dollars on critically needed gloves they will never receive,” says V12 Health Founder and CEO, Tarek Kirschen.
V12 Health is an FDA registered and ISO 9001 certified manufacturer of medical and chemo rated Nitrile gloves, TPE gloves, and medical gowns. At the height of the pandemic in 2020 they opened doors in Miami and transitioned to manufacturing their own line of products, moving away from dependence on Malaysia and Thailand, which currently supplies more than 60 percent of the global gloves market.
“We saw ethical, logistical, and quality-control issues coming out of Southeast Asian factories last year,” says Kirschen. “I am proud that we are a part of the solution by providing high-quality gloves and gowns to our frontline workers – they are the true heroes in this pandemic.”
V12 Health’s manufacturing facilities adhere to the ISO 9001 Quality Management Standard. ISO 9001 sets the criteria for a quality management system and is based on a number of principles, including a strong customer focus, the motivation and implication of top management, the process approach and continual improvement. Using ISO 9001 helps ensure that customers get consistent, good-quality products and services, which in turn brings many business benefits.
V12 Health’s line of gloves and gowns was constructed with top engineering tactics, strict quality controls, and adherence to international and US standards such as ISO 9001 and USP 800. All gloves and gowns are shipped directly from V12 Health factories to clients around the world.
With headquarters in Miami and offices in Frankfurt, Istanbul, and Shenzhen, the rapidly growing company is looking to expand into Latin America in the Second Quarter of 2021.